These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 32844483)
21. Comparison of cycloplegia at 20- and 30-minutes following proxymetacaine and cyclopentolate instillation in white 12-13-year-olds. Doyle M; O' Dwyer V; Harrington S Clin Exp Optom; 2023 Nov; 106(8):890-895. PubMed ID: 36750050 [TBL] [Abstract][Full Text] [Related]
22. Incidence of side effects of topical atropine sulfate and cyclopentolate hydrochloride for cycloplegia in Japanese children: a multicenter study. Wakayama A; Nishina S; Miki A; Utsumi T; Sugasawa J; Hayashi T; Sato M; Kimura A; Fujikado T Jpn J Ophthalmol; 2018 Sep; 62(5):531-536. PubMed ID: 30046935 [TBL] [Abstract][Full Text] [Related]
23. [Research on whether atropine can be substituted by the powerful cycloplegic cyclopentolate]. Xu JT Zhonghua Yan Ke Za Zhi; 2012 Sep; 48(9):772-5. PubMed ID: 23141569 [TBL] [Abstract][Full Text] [Related]
24. Cycloplegic refraction in esotropic children. Cyclopentolate versus atropine. Rosenbaum AL; Bateman JB; Bremer DL; Liu PY Ophthalmology; 1981 Oct; 88(10):1031-4. PubMed ID: 7335305 [TBL] [Abstract][Full Text] [Related]
25. Comparison of the Near Eye Tool for Refractive Assessment (NETRA) and non-cycloplegic subjective refraction. Hasrod N; Rubin A BMJ Open Ophthalmol; 2022; 7(1):e000851. PubMed ID: 35452206 [TBL] [Abstract][Full Text] [Related]
26. What is the appropriate age cut-off for cycloplegia in refraction? Sanfilippo PG; Chu BS; Bigault O; Kearns LS; Boon MY; Young TL; Hammond CJ; Hewitt AW; Mackey DA Acta Ophthalmol; 2014 Sep; 92(6):e458-62. PubMed ID: 24641244 [TBL] [Abstract][Full Text] [Related]
27. Effect of cyclopentolate versus tropicamide on anterior segment angle parameters in three refractive groups. Moghadas Sharif N; Shoeibi N; Heydari M; Yazdani N; Ghasemi-Moghaddam S; Ehsaei A Clin Exp Optom; 2021 Mar; 104(2):151-155. PubMed ID: 32519368 [TBL] [Abstract][Full Text] [Related]
28. The interaction between homatropine and optical blur on choroidal thickness. Sander BP; Collins MJ; Read SA Ophthalmic Physiol Opt; 2018 May; 38(3):257-265. PubMed ID: 29691923 [TBL] [Abstract][Full Text] [Related]
29. The effect of topical administration of cyclopentolate on ocular biometry: An analysis for mouse and human models. Huang F; Huang S; Xie R; Yang Y; Yan J; Cao X; Zhang C; Zhou F; Shen M; Qu J; Zhou X Sci Rep; 2017 Aug; 7(1):9952. PubMed ID: 28855546 [TBL] [Abstract][Full Text] [Related]
30. [Cycloplegia with cyclopentolate for testing-refraction of children (author's transl)]. Stangler-Zuschrott E Klin Monbl Augenheilkd; 1979 Jul; 175(1):95-9. PubMed ID: 582836 [TBL] [Abstract][Full Text] [Related]
31. Comparison of noncycloplegic and cycloplegic autorefraction in categorizing refractive error data in children. Sankaridurg P; He X; Naduvilath T; Lv M; Ho A; Smith E; Erickson P; Zhu J; Zou H; Xu X Acta Ophthalmol; 2017 Nov; 95(7):e633-e640. PubMed ID: 29110438 [TBL] [Abstract][Full Text] [Related]
32. Optimal dosage of cyclopentolate 1% for complete cycloplegia: a randomized clinical trial. Bagheri A; Givrad S; Yazdani S; Reza Mohebbi M Eur J Ophthalmol; 2007; 17(3):294-300. PubMed ID: 17534806 [TBL] [Abstract][Full Text] [Related]
33. Effects of atropine and tropicamide on ocular biological parameters in children: a prospective observational study. Tao Y; Li M; Tan J; Huang J; Cheng X; Xie P; Liu X; Zhou Q; Ouyang J BMC Ophthalmol; 2023 Mar; 23(1):96. PubMed ID: 36915059 [TBL] [Abstract][Full Text] [Related]
34. The effect of cycloplegia on measurement of the ocular components. Mutti DO; Zadnik K; Egashira S; Kish L; Twelker JD; Adams AJ Invest Ophthalmol Vis Sci; 1994 Feb; 35(2):515-27. PubMed ID: 8113002 [TBL] [Abstract][Full Text] [Related]
35. The difference between cycloplegic and non-cycloplegic autorefraction and its association with progression of refractive error in Beijing urban children. Lin Z; Vasudevan B; Ciuffreda KJ; Zhou HJ; Mao GY; Wang NL; Liang YB Ophthalmic Physiol Opt; 2017 Jul; 37(4):489-497. PubMed ID: 28503812 [TBL] [Abstract][Full Text] [Related]
37. Analysis of Changes in Refraction and Biometry of Atropine- and Placebo-Treated Eyes. Kumaran A; Htoon HM; Tan D; Chia A Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5650-5. PubMed ID: 26313301 [TBL] [Abstract][Full Text] [Related]
38. The effect of cycloplegia on biometric measurements using swept-source optical coherence tomography-based biometry. Ozcaliskan S; Yenerel NM Clin Exp Optom; 2019 Sep; 102(5):501-505. PubMed ID: 30834574 [TBL] [Abstract][Full Text] [Related]
39. Differential Effects on Ocular Biometrics by 0.05%, 0.025%, and 0.01% Atropine: Low-Concentration Atropine for Myopia Progression Study. Li FF; Kam KW; Zhang Y; Tang SM; Young AL; Chen LJ; Tham CC; Pang CP; Yam JC Ophthalmology; 2020 Dec; 127(12):1603-1611. PubMed ID: 32525048 [TBL] [Abstract][Full Text] [Related]
40. Cost-effectiveness of cycloplegic agents: results of a randomized controlled trial in nigerian children. Ebri A; Kuper H; Wedner S Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1025-31. PubMed ID: 17325142 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]